Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for RARG
Z-value: 3.75
Motif logo
Transcription factors associated with RARG
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
RARG
|
ENSG00000172819.17 | RARG |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| RARG | hg38_v1_chr12_-_53232182_53232256 | -0.11 | 1.1e-01 | Click! |
Activity profile of RARG motif
Sorted Z-values of RARG motif
Network of associatons between targets according to the STRING database.
First level regulatory network of RARG
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.4 | 19.3 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 4.9 | 14.8 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 4.5 | 13.4 | GO:0051946 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 3.5 | 14.0 | GO:0009956 | radial pattern formation(GO:0009956) |
| 3.5 | 10.4 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 3.5 | 10.4 | GO:1900154 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 3.4 | 13.6 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 3.3 | 19.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 3.1 | 9.3 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 2.9 | 11.6 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 2.9 | 14.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 2.8 | 11.3 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 2.8 | 8.4 | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
| 2.6 | 10.6 | GO:0032262 | pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) |
| 2.6 | 20.8 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 2.5 | 15.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 2.5 | 7.4 | GO:2000276 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 2.4 | 12.0 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
| 2.4 | 21.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 2.4 | 11.8 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 2.4 | 21.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 2.3 | 9.3 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
| 2.2 | 8.8 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 2.2 | 15.3 | GO:0030421 | defecation(GO:0030421) |
| 2.2 | 15.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 2.1 | 10.7 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 2.1 | 16.7 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 2.1 | 14.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 2.0 | 8.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 2.0 | 10.0 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 2.0 | 17.8 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 2.0 | 5.9 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
| 2.0 | 11.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 1.9 | 11.6 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 1.9 | 5.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 1.9 | 7.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.8 | 23.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 1.8 | 18.0 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 1.8 | 5.3 | GO:0061445 | endocardial cell fate commitment(GO:0060957) endocardial cushion cell fate commitment(GO:0061445) |
| 1.7 | 1.7 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 1.7 | 5.2 | GO:0002368 | B cell cytokine production(GO:0002368) |
| 1.7 | 32.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 1.7 | 5.0 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 1.7 | 28.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 1.6 | 4.8 | GO:0042823 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 1.6 | 15.7 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 1.5 | 6.2 | GO:0031179 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 1.5 | 7.6 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 1.4 | 5.8 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 1.4 | 4.3 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 1.4 | 4.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 1.4 | 14.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 1.4 | 11.3 | GO:0097033 | mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 1.4 | 4.2 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 1.4 | 4.2 | GO:0007174 | epidermal growth factor catabolic process(GO:0007174) |
| 1.4 | 4.2 | GO:0060382 | release from viral latency(GO:0019046) regulation of DNA strand elongation(GO:0060382) |
| 1.4 | 22.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 1.4 | 5.5 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 1.4 | 5.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 1.4 | 13.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 1.4 | 17.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 1.4 | 4.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 1.3 | 6.6 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 1.3 | 10.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 1.3 | 11.9 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 1.3 | 22.2 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 1.3 | 6.5 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 1.3 | 6.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 1.3 | 3.8 | GO:0014873 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 1.3 | 83.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 1.2 | 6.2 | GO:0030242 | pexophagy(GO:0030242) |
| 1.2 | 1.2 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 1.2 | 13.7 | GO:0006108 | malate metabolic process(GO:0006108) |
| 1.2 | 17.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 1.2 | 22.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 1.2 | 3.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 1.2 | 15.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 1.2 | 3.5 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 1.2 | 28.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 1.2 | 2.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 1.2 | 3.5 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 1.1 | 5.7 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 1.1 | 5.6 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 1.1 | 6.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 1.0 | 7.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 1.0 | 4.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.0 | 3.0 | GO:0060166 | olfactory pit development(GO:0060166) |
| 1.0 | 5.9 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 1.0 | 5.8 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 1.0 | 4.9 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
| 1.0 | 1.9 | GO:0032900 | negative regulation of neurotrophin production(GO:0032900) |
| 1.0 | 5.7 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.9 | 2.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.9 | 4.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.9 | 4.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.9 | 6.5 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.9 | 4.6 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
| 0.9 | 3.6 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.9 | 2.6 | GO:0019878 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 0.9 | 15.7 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.9 | 4.3 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
| 0.9 | 1.7 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.9 | 4.3 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.8 | 5.1 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.8 | 10.8 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.8 | 7.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.8 | 10.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.8 | 4.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.8 | 20.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.8 | 4.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.8 | 16.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.8 | 7.1 | GO:2000582 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.8 | 4.7 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.8 | 20.3 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.8 | 10.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
| 0.8 | 2.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 0.8 | 2.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 0.8 | 2.3 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
| 0.8 | 6.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.8 | 6.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.8 | 5.3 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.8 | 5.3 | GO:0035989 | tendon development(GO:0035989) |
| 0.7 | 2.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 0.7 | 3.7 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.7 | 5.2 | GO:2000230 | regulation of cholesterol transporter activity(GO:0060694) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.7 | 11.1 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.7 | 2.2 | GO:0051939 | gamma-aminobutyric acid import(GO:0051939) |
| 0.7 | 3.6 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
| 0.7 | 4.2 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.7 | 3.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.7 | 4.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.7 | 7.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.7 | 1.4 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
| 0.7 | 2.1 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
| 0.7 | 2.1 | GO:1903567 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.7 | 4.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.7 | 2.8 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.7 | 5.4 | GO:0015677 | copper ion import(GO:0015677) |
| 0.7 | 2.0 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.7 | 7.8 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.6 | 2.6 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.6 | 2.6 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.6 | 1.3 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.6 | 1.9 | GO:0042704 | uterine wall breakdown(GO:0042704) |
| 0.6 | 5.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.6 | 48.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.6 | 3.2 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
| 0.6 | 5.0 | GO:0006203 | dGTP catabolic process(GO:0006203) |
| 0.6 | 2.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.6 | 9.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.6 | 3.7 | GO:0032916 | positive regulation of transforming growth factor beta3 production(GO:0032916) negative regulation of lung blood pressure(GO:0061767) |
| 0.6 | 3.7 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.6 | 3.1 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.6 | 1.8 | GO:0097698 | telomere maintenance via base-excision repair(GO:0097698) |
| 0.6 | 9.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.6 | 0.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.6 | 9.5 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.6 | 12.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.6 | 2.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.6 | 1.7 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
| 0.6 | 2.8 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.6 | 3.9 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.6 | 7.3 | GO:2001171 | regulation of ATP biosynthetic process(GO:2001169) positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.6 | 2.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
| 0.5 | 3.3 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.5 | 3.3 | GO:0009624 | response to nematode(GO:0009624) |
| 0.5 | 4.9 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.5 | 3.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.5 | 10.2 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.5 | 2.1 | GO:2000612 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.5 | 7.4 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.5 | 7.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.5 | 1.6 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.5 | 6.7 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.5 | 1.5 | GO:0007500 | mesodermal cell fate determination(GO:0007500) negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.5 | 6.7 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.5 | 1.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.5 | 9.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.5 | 2.5 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.5 | 6.4 | GO:1900623 | monocyte aggregation(GO:0070487) regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.5 | 8.4 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.5 | 2.9 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.5 | 1.9 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
| 0.5 | 5.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.5 | 1.4 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.5 | 2.3 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.5 | 1.4 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.5 | 1.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.4 | 7.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.4 | 3.9 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.4 | 5.6 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.4 | 3.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.4 | 0.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.4 | 7.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.4 | 4.2 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.4 | 2.5 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.4 | 2.8 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.4 | 5.2 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.4 | 6.4 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.4 | 0.4 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.4 | 1.6 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 0.4 | 2.3 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.4 | 4.9 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.4 | 5.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.4 | 3.3 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
| 0.4 | 1.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.4 | 1.8 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.4 | 1.1 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.4 | 1.5 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.4 | 4.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.4 | 3.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.4 | 3.9 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
| 0.4 | 2.8 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
| 0.4 | 3.2 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.4 | 6.0 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
| 0.4 | 1.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) snoRNA localization(GO:0048254) |
| 0.3 | 2.4 | GO:0070885 | positive regulation of sodium:proton antiporter activity(GO:0032417) negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.3 | 3.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.3 | 3.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.3 | 17.1 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.3 | 5.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.3 | 1.0 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.3 | 0.7 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.3 | 1.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.3 | 14.8 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.3 | 4.9 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.3 | 1.6 | GO:0001315 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.3 | 1.6 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 0.3 | 8.3 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.3 | 2.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.3 | 2.5 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.3 | 0.6 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.3 | 0.9 | GO:0071484 | response to high light intensity(GO:0009644) cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) retinal cell apoptotic process(GO:1990009) |
| 0.3 | 1.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.3 | 2.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.3 | 4.5 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
| 0.3 | 2.7 | GO:0042407 | cristae formation(GO:0042407) |
| 0.3 | 5.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.3 | 4.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.3 | 5.6 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.3 | 8.5 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
| 0.3 | 0.6 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
| 0.3 | 1.1 | GO:0072143 | mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.3 | 1.7 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.3 | 0.8 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.3 | 1.4 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 0.3 | 2.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.3 | 7.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.3 | 3.0 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.3 | 4.4 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.3 | 2.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.3 | 2.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.3 | 2.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.3 | 0.8 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.3 | 5.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.3 | 5.3 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.3 | 2.9 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.3 | 1.3 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.3 | 8.3 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.3 | 6.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.3 | 3.6 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.3 | 0.8 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.3 | 2.3 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.2 | 2.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.2 | 1.5 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.2 | 1.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.2 | 2.2 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.2 | 9.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.2 | 0.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.2 | 6.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.2 | 9.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.2 | 0.5 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.2 | 1.9 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.2 | 0.5 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.2 | 2.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.2 | 0.7 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.2 | 5.1 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.2 | 0.7 | GO:0090403 | optic cup formation involved in camera-type eye development(GO:0003408) oxidative stress-induced premature senescence(GO:0090403) |
| 0.2 | 7.2 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.2 | 0.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.2 | 0.7 | GO:0043301 | negative regulation of leukocyte degranulation(GO:0043301) |
| 0.2 | 1.6 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.2 | 0.7 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.2 | 2.7 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.2 | 3.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 | 10.6 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
| 0.2 | 4.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.2 | 0.4 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.2 | 3.1 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.2 | 0.9 | GO:0048627 | myoblast development(GO:0048627) |
| 0.2 | 0.9 | GO:1903971 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.2 | 2.2 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.2 | 2.6 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.2 | 1.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.2 | 0.8 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.2 | 8.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.2 | 1.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 | 1.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.2 | 1.0 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.2 | 4.0 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
| 0.2 | 1.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.2 | 1.0 | GO:1901094 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.2 | 0.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.2 | 1.9 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
| 0.2 | 0.9 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.2 | 1.1 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.2 | 1.5 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.2 | 0.5 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
| 0.2 | 0.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 | 0.5 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.2 | 1.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.2 | 1.2 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.2 | 5.7 | GO:0046655 | folic acid metabolic process(GO:0046655) |
| 0.2 | 1.2 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.2 | 1.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.2 | 5.0 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.2 | 1.2 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.2 | 0.2 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.2 | 5.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.2 | 1.9 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.2 | 1.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.2 | 0.7 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.2 | 0.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 | 1.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.2 | 2.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.2 | 0.2 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.2 | 11.0 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.2 | 1.3 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.2 | 3.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 | 4.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.2 | 2.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.2 | 1.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.2 | 9.2 | GO:0090109 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) |
| 0.2 | 2.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.2 | 2.0 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) |
| 0.2 | 2.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.2 | 5.6 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.2 | 11.6 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.2 | 0.6 | GO:0015879 | carnitine transport(GO:0015879) |
| 0.1 | 0.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 | 1.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
| 0.1 | 0.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.1 | 0.6 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.1 | 1.9 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.1 | 0.4 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.1 | 2.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 | 1.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 3.0 | GO:0032288 | myelin assembly(GO:0032288) |
| 0.1 | 1.1 | GO:0070141 | response to UV-A(GO:0070141) cellular response to UV-A(GO:0071492) |
| 0.1 | 1.0 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.1 | 2.0 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.1 | 3.3 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.1 | 1.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.1 | 9.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 | 0.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 0.1 | 1.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.1 | 6.0 | GO:0051693 | actin filament capping(GO:0051693) |
| 0.1 | 2.4 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.1 | 0.5 | GO:0050916 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
| 0.1 | 1.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 1.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 | 3.9 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.1 | 0.5 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.1 | 1.6 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
| 0.1 | 0.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.1 | 6.1 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.1 | 7.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.1 | 1.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 0.1 | 0.7 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
| 0.1 | 0.5 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 0.1 | 0.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.1 | 5.4 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.1 | 1.1 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
| 0.1 | 1.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 1.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 0.3 | GO:2000391 | positive regulation of neutrophil extravasation(GO:2000391) positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.1 | 2.7 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.1 | 0.9 | GO:0097034 | mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 | 2.2 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.1 | 2.8 | GO:0030325 | adrenal gland development(GO:0030325) |
| 0.1 | 1.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.1 | 1.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.1 | 4.1 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.1 | 1.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 | 2.8 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 0.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 2.6 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.1 | 0.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.1 | 1.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.1 | 1.3 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
| 0.1 | 1.5 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 | 0.2 | GO:0044571 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) [2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 | 0.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 0.7 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 | 7.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 | 3.0 | GO:0001541 | ovarian follicle development(GO:0001541) |
| 0.1 | 0.9 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 1.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 3.0 | GO:0021762 | substantia nigra development(GO:0021762) |
| 0.1 | 0.5 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 | 6.5 | GO:0060996 | dendritic spine development(GO:0060996) |
| 0.1 | 0.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.1 | 0.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 | 3.5 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.1 | 0.2 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
| 0.1 | 1.0 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 1.8 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.1 | 1.6 | GO:0006582 | melanin metabolic process(GO:0006582) |
| 0.1 | 2.1 | GO:0015800 | acidic amino acid transport(GO:0015800) |
| 0.1 | 1.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.1 | 1.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.1 | 1.0 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 0.1 | 2.8 | GO:0033048 | negative regulation of mitotic sister chromatid segregation(GO:0033048) negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.1 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.1 | 0.5 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 0.9 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
| 0.1 | 3.3 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 | 3.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 | 0.3 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.1 | 0.2 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.1 | 3.2 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.1 | 27.5 | GO:0043687 | post-translational protein modification(GO:0043687) |
| 0.1 | 1.4 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 | 1.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.1 | 7.5 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 0.1 | 1.9 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
| 0.1 | 1.7 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.1 | 1.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.1 | 2.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.1 | 2.2 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 | 1.4 | GO:0030728 | ovulation(GO:0030728) |
| 0.1 | 1.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.1 | 9.6 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.1 | 1.3 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
| 0.1 | 0.8 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.1 | 0.6 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
| 0.1 | 1.4 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
| 0.1 | 5.7 | GO:0001764 | neuron migration(GO:0001764) |
| 0.1 | 0.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.1 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.1 | 0.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.1 | 1.7 | GO:0003091 | renal water homeostasis(GO:0003091) |
| 0.1 | 2.4 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
| 0.1 | 1.7 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.0 | 0.6 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.0 | 0.9 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.0 | 0.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 | 0.4 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
| 0.0 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 | 4.2 | GO:0030048 | actin filament-based movement(GO:0030048) |
| 0.0 | 2.0 | GO:0007032 | endosome organization(GO:0007032) |
| 0.0 | 0.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.0 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
| 0.0 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.0 | 0.5 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.0 | 0.8 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.0 | 0.4 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.0 | 0.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 | 0.7 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.0 | 0.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.0 | 0.5 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.0 | 3.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 0.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 | 0.4 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.0 | 0.5 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 | 0.0 | GO:0052199 | negative regulation by host of viral process(GO:0044793) negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.0 | 0.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.0 | 0.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.0 | 0.5 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 0.0 | 1.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.0 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.0 | 0.2 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.0 | 0.2 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.0 | 0.1 | GO:0006833 | water transport(GO:0006833) |
| 0.0 | 0.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.0 | 0.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.0 | 0.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 | 0.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.0 | 0.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.0 | 0.8 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.0 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 1.1 | GO:0031032 | actomyosin structure organization(GO:0031032) |
| 0.0 | 0.7 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.5 | 22.7 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 3.9 | 15.5 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 2.9 | 17.5 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 1.9 | 17.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 1.9 | 5.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.9 | 24.5 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 1.8 | 7.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 1.8 | 5.3 | GO:0005592 | collagen type XI trimer(GO:0005592) |
| 1.7 | 10.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 1.6 | 17.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 1.5 | 26.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 1.5 | 7.3 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 1.4 | 4.2 | GO:0032419 | extrinsic component of lysosome membrane(GO:0032419) |
| 1.3 | 5.3 | GO:0048179 | activin receptor complex(GO:0048179) |
| 1.3 | 7.8 | GO:0061617 | MICOS complex(GO:0061617) |
| 1.3 | 13.0 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 1.3 | 6.4 | GO:0043291 | RAVE complex(GO:0043291) |
| 1.2 | 10.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 1.1 | 14.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 1.1 | 3.2 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 1.1 | 6.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 1.0 | 4.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 1.0 | 6.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 1.0 | 11.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 1.0 | 57.7 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 1.0 | 3.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 1.0 | 3.9 | GO:0071817 | MMXD complex(GO:0071817) |
| 1.0 | 15.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 1.0 | 3.8 | GO:0071942 | XPC complex(GO:0071942) |
| 0.9 | 15.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.9 | 2.8 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.9 | 4.7 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.9 | 5.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.9 | 7.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.9 | 19.9 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.9 | 28.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.8 | 7.6 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.8 | 5.5 | GO:0031415 | NatA complex(GO:0031415) |
| 0.8 | 3.1 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.8 | 5.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.8 | 3.9 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.8 | 3.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.8 | 2.3 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.7 | 6.7 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.7 | 3.0 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.7 | 19.1 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.7 | 28.2 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.7 | 6.9 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.7 | 8.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.7 | 4.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.7 | 6.1 | GO:0045180 | basal cortex(GO:0045180) |
| 0.7 | 5.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.6 | 10.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.6 | 3.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 0.6 | 4.4 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.6 | 3.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.6 | 10.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.6 | 1.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.6 | 14.1 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.6 | 7.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.6 | 8.5 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.6 | 4.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.6 | 3.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.6 | 2.4 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.6 | 35.8 | GO:0043034 | costamere(GO:0043034) |
| 0.6 | 6.4 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.6 | 16.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.6 | 11.8 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.5 | 140.1 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.5 | 12.9 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.5 | 5.3 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.5 | 3.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.5 | 8.7 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.5 | 4.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.5 | 3.7 | GO:0000796 | condensin complex(GO:0000796) |
| 0.4 | 3.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.4 | 1.7 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.4 | 7.3 | GO:0008091 | spectrin(GO:0008091) |
| 0.4 | 3.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.4 | 2.8 | GO:0090661 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.4 | 4.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.4 | 1.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.4 | 2.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.4 | 2.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.4 | 3.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.3 | 15.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.3 | 2.7 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.3 | 2.0 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.3 | 0.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.3 | 6.1 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.3 | 8.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.3 | 1.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.3 | 7.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.3 | 4.9 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.3 | 6.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.3 | 6.7 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
| 0.3 | 16.4 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.3 | 6.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.3 | 1.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.3 | 5.9 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.3 | 2.2 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.3 | 5.5 | GO:0016342 | catenin complex(GO:0016342) |
| 0.3 | 24.2 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.3 | 1.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 0.3 | 14.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.3 | 1.1 | GO:0035841 | new growing cell tip(GO:0035841) |
| 0.3 | 6.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.3 | 3.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.3 | 4.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.3 | 2.3 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.3 | 2.0 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.3 | 2.8 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.2 | 8.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.2 | 3.9 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.2 | 3.9 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.2 | 18.1 | GO:0030315 | T-tubule(GO:0030315) |
| 0.2 | 3.2 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.2 | 1.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.2 | 4.5 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.2 | 0.9 | GO:0032449 | CBM complex(GO:0032449) |
| 0.2 | 4.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.2 | 0.9 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.2 | 1.5 | GO:0032021 | NELF complex(GO:0032021) |
| 0.2 | 2.5 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.2 | 11.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.2 | 5.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.2 | 2.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.2 | 1.0 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.2 | 1.8 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.2 | 2.7 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.2 | 1.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.2 | 0.6 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.2 | 0.6 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.2 | 2.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 0.2 | 1.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.2 | 2.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.2 | 8.1 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.2 | 1.2 | GO:0016589 | NURF complex(GO:0016589) |
| 0.2 | 16.7 | GO:0005604 | basement membrane(GO:0005604) |
| 0.2 | 0.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.2 | 2.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.2 | 1.1 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.2 | 4.1 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.2 | 1.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.2 | 23.9 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 1.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 3.7 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 4.8 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 0.1 | 1.1 | GO:0031968 | organelle outer membrane(GO:0031968) |
| 0.1 | 1.1 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 4.9 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 4.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 6.7 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 15.6 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 1.2 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
| 0.1 | 3.4 | GO:0097546 | ciliary base(GO:0097546) |
| 0.1 | 13.4 | GO:0043204 | perikaryon(GO:0043204) |
| 0.1 | 1.5 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 1.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 41.8 | GO:0005874 | microtubule(GO:0005874) |
| 0.1 | 0.6 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.1 | 11.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 0.2 | GO:1990879 | CST complex(GO:1990879) |
| 0.1 | 2.6 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 0.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.1 | 9.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.1 | 1.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 16.4 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.1 | 2.5 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 1.1 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.1 | 5.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 4.6 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 0.5 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 1.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 4.5 | GO:0042641 | actomyosin(GO:0042641) |
| 0.1 | 1.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 6.2 | GO:0000922 | spindle pole(GO:0000922) |
| 0.1 | 2.8 | GO:0031430 | M band(GO:0031430) |
| 0.1 | 0.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.1 | 20.8 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.1 | 23.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 2.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 6.5 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.1 | 2.8 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 2.3 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.1 | 1.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 3.4 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 5.4 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.1 | 1.3 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.1 | 0.5 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 3.0 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 8.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.0 | 3.2 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 1.5 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 15.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 1.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 19.3 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.0 | 1.3 | GO:0008305 | integrin complex(GO:0008305) |
| 0.0 | 3.7 | GO:0030426 | growth cone(GO:0030426) |
| 0.0 | 2.1 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.0 | 1.0 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.0 | 4.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 27.5 | GO:0005730 | nucleolus(GO:0005730) |
| 0.0 | 2.4 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.0 | 0.2 | GO:0060076 | excitatory synapse(GO:0060076) |
| 0.0 | 2.1 | GO:0031514 | motile cilium(GO:0031514) |
| 0.0 | 0.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.0 | 12.3 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 0.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.0 | 0.9 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
| 0.0 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.0 | 3.6 | GO:0005770 | late endosome(GO:0005770) |
| 0.0 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
| 0.0 | 0.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.8 | 14.4 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 4.5 | 17.9 | GO:0004420 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
| 3.8 | 11.3 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 3.7 | 14.8 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 3.5 | 10.5 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 3.1 | 15.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 2.7 | 8.2 | GO:0000035 | acyl binding(GO:0000035) |
| 2.7 | 21.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 2.6 | 18.4 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
| 2.6 | 20.8 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 2.6 | 10.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 2.5 | 7.6 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
| 2.5 | 7.4 | GO:0048030 | disaccharide binding(GO:0048030) |
| 2.4 | 19.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 2.4 | 19.1 | GO:0015288 | porin activity(GO:0015288) |
| 2.4 | 7.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 2.2 | 13.4 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 2.2 | 17.7 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 2.2 | 8.6 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 2.1 | 8.4 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 2.0 | 6.1 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 2.0 | 6.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 1.9 | 13.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 1.9 | 7.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 1.9 | 9.3 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 1.8 | 12.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 1.8 | 7.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 1.8 | 5.3 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 1.7 | 5.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 1.7 | 5.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 1.7 | 8.4 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 1.7 | 15.2 | GO:0016015 | morphogen activity(GO:0016015) |
| 1.7 | 5.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 1.7 | 87.9 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 1.7 | 11.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 1.6 | 20.8 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 1.6 | 4.8 | GO:0031403 | lithium ion binding(GO:0031403) |
| 1.6 | 25.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 1.5 | 6.2 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 1.5 | 4.5 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
| 1.5 | 5.9 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 1.4 | 5.8 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 1.4 | 11.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 1.4 | 5.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 1.4 | 4.2 | GO:0070052 | collagen V binding(GO:0070052) |
| 1.4 | 6.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 1.2 | 1.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 1.2 | 4.9 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 1.2 | 3.5 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 1.2 | 5.9 | GO:0045174 | glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 1.2 | 4.7 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 1.1 | 3.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 1.1 | 1.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 1.1 | 5.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 1.1 | 5.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 1.0 | 9.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.9 | 7.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.9 | 4.7 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.9 | 5.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.9 | 2.8 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.9 | 27.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.9 | 4.6 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.9 | 7.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.9 | 3.6 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.9 | 3.6 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.9 | 13.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.9 | 5.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.9 | 4.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.8 | 17.8 | GO:0031402 | sodium ion binding(GO:0031402) |
| 0.8 | 3.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.8 | 4.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.8 | 8.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.8 | 8.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.8 | 14.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.8 | 3.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.8 | 6.9 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.8 | 18.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.8 | 7.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.8 | 10.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.8 | 15.8 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.7 | 2.2 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.7 | 3.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.7 | 2.2 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.7 | 2.2 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.7 | 2.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.7 | 9.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.7 | 11.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.7 | 2.1 | GO:0034512 | box C/D snoRNA binding(GO:0034512) |
| 0.7 | 4.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.7 | 10.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.7 | 2.7 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.7 | 2.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.6 | 3.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.6 | 8.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.6 | 2.6 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.6 | 9.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.6 | 3.8 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.6 | 3.8 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.6 | 3.7 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.6 | 1.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.6 | 3.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.6 | 4.2 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.6 | 3.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.6 | 8.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.6 | 1.8 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.6 | 5.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.6 | 2.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.6 | 6.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.6 | 2.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.5 | 2.2 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.5 | 3.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.5 | 2.7 | GO:0019862 | IgA binding(GO:0019862) |
| 0.5 | 0.5 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 0.5 | 2.6 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
| 0.5 | 1.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 0.5 | 5.2 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.5 | 2.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.5 | 3.0 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.5 | 0.5 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.5 | 10.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.5 | 2.9 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.5 | 1.9 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.5 | 2.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.5 | 6.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.5 | 1.9 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.5 | 1.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.5 | 1.4 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.5 | 1.8 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 0.4 | 12.6 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.4 | 4.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.4 | 3.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.4 | 2.2 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 0.4 | 2.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.4 | 2.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.4 | 7.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.4 | 2.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.4 | 2.8 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.4 | 4.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.4 | 2.8 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.4 | 1.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.4 | 2.7 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.4 | 16.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.4 | 10.9 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.4 | 1.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.4 | 13.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.4 | 3.0 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.4 | 9.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.4 | 9.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.4 | 5.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.4 | 8.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.4 | 2.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.4 | 1.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.3 | 1.0 | GO:0032428 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
| 0.3 | 1.7 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.3 | 2.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 0.3 | 2.1 | GO:0052658 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.3 | 5.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.3 | 5.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.3 | 2.0 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.3 | 32.5 | GO:0003774 | motor activity(GO:0003774) |
| 0.3 | 5.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.3 | 1.0 | GO:0031691 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) V2 vasopressin receptor binding(GO:0031896) |
| 0.3 | 11.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.3 | 9.2 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.3 | 14.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.3 | 38.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.3 | 6.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.3 | 1.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.3 | 8.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.3 | 3.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.3 | 0.9 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.3 | 5.0 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.3 | 0.9 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 0.3 | 1.7 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.3 | 0.8 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 0.3 | 8.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.3 | 2.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.3 | 3.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.3 | 2.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.3 | 2.4 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.3 | 26.6 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.3 | 5.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.3 | 1.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.3 | 3.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.3 | 3.8 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.3 | 2.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.3 | 3.3 | GO:0048185 | activin binding(GO:0048185) |
| 0.3 | 3.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.3 | 2.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.3 | 4.5 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.2 | 19.0 | GO:0019003 | GDP binding(GO:0019003) |
| 0.2 | 7.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.2 | 7.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.2 | 8.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.2 | 1.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.2 | 12.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.2 | 1.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.2 | 2.9 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.2 | 3.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.2 | 4.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.2 | 36.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.2 | 8.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 6.7 | GO:0001848 | complement binding(GO:0001848) |
| 0.2 | 7.1 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 4.4 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.2 | 0.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 0.2 | 2.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.2 | 0.9 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.2 | 3.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.2 | 1.8 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.2 | 1.5 | GO:0005534 | galactose binding(GO:0005534) |
| 0.2 | 3.5 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 1.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.2 | 6.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.2 | 6.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.2 | 1.2 | GO:0016918 | retinal binding(GO:0016918) |
| 0.2 | 6.6 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.2 | 2.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.2 | 1.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.2 | 4.8 | GO:0043236 | laminin binding(GO:0043236) |
| 0.2 | 3.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 3.3 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.2 | 1.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.2 | 0.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.2 | 0.9 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.2 | 0.3 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 0.2 | 4.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.2 | 2.3 | GO:0031386 | protein tag(GO:0031386) |
| 0.2 | 2.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
| 0.2 | 4.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.2 | 10.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.2 | 3.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.2 | 16.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.2 | 0.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.2 | 0.5 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.2 | 0.6 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.2 | 5.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 2.1 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 2.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.1 | 2.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 1.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 0.8 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 0.1 | 1.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.1 | 8.5 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
| 0.1 | 4.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.1 | 3.0 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.1 | 4.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 0.5 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.1 | 22.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 1.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 1.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.1 | 5.9 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
| 0.1 | 2.1 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 1.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.1 | 1.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 31.0 | GO:0005525 | GTP binding(GO:0005525) |
| 0.1 | 1.0 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.1 | 0.5 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.1 | 14.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.1 | 4.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 1.5 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.1 | 5.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.1 | 8.4 | GO:0005518 | collagen binding(GO:0005518) |
| 0.1 | 2.1 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.1 | 3.2 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 11.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.1 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.1 | 0.8 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.1 | 3.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 14.2 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.1 | 3.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
| 0.1 | 0.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.1 | 2.3 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.1 | 0.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 0.1 | 0.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.1 | 13.7 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.1 | 0.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 0.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 6.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.1 | 0.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 2.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.1 | 2.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.1 | 0.4 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.1 | 0.2 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.1 | 6.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.1 | 1.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.1 | 0.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.1 | 0.4 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.1 | 2.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 0.3 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.1 | 1.5 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.1 | 0.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 1.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.1 | 18.1 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 0.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 1.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.2 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.1 | 0.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.1 | 1.2 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.1 | 1.6 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 0.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.1 | 0.7 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.1 | 0.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.0 | 0.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.0 | 0.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.0 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.0 | 0.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.0 | 1.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.0 | 0.2 | GO:0033743 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.0 | 0.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.0 | 0.2 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 0.0 | 0.1 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.0 | 1.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.0 | 0.6 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
| 0.0 | 0.1 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.0 | 1.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
| 0.0 | 0.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.0 | 1.5 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.0 | 1.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.0 | 0.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.0 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.0 | 0.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.0 | 1.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 1.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 2.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 0.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.0 | 0.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.0 | 1.1 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.0 | 0.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 0.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.0 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.0 | 0.8 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
| 0.0 | 0.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 0.9 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.0 | 1.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.0 | 0.3 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 0.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.0 | 0.2 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.0 | 0.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.0 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.0 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 0.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.0 | 0.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) phospholipase D activity(GO:0004630) |
| 0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 1.0 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
| 0.0 | 1.0 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 22.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 1.2 | 33.3 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.9 | 54.1 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.7 | 18.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.6 | 46.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.5 | 35.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.5 | 3.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.5 | 5.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.5 | 19.1 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.5 | 13.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.4 | 43.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.4 | 12.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.4 | 3.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.3 | 22.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.3 | 6.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 10.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.3 | 16.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.3 | 5.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.3 | 34.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.3 | 1.4 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.3 | 4.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.3 | 13.0 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.3 | 17.2 | PID FOXO PATHWAY | FoxO family signaling |
| 0.3 | 1.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.2 | 19.5 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.2 | 3.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.2 | 11.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.2 | 6.3 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.2 | 7.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.2 | 0.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 2.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 6.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.2 | 0.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.2 | 7.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.2 | 7.1 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.2 | 2.6 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 10.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 3.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 7.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 5.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 7.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 3.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 23.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 6.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.1 | 6.6 | PID BMP PATHWAY | BMP receptor signaling |
| 0.1 | 5.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 1.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.1 | 7.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 1.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 5.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 6.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.1 | 1.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.1 | 1.8 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.1 | 1.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 1.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.1 | 1.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 2.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 1.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 1.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 3.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.1 | 3.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 3.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.1 | 4.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 3.8 | PID E2F PATHWAY | E2F transcription factor network |
| 0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.1 | 2.1 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 0.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.0 | 5.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 0.5 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.0 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 0.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 0.4 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.0 | 1.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 41.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 1.6 | 137.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 1.5 | 41.3 | REACTOME KINESINS | Genes involved in Kinesins |
| 1.4 | 17.8 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 1.1 | 21.7 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.9 | 52.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.9 | 13.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.8 | 27.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.8 | 13.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.8 | 27.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.8 | 8.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.7 | 14.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.6 | 34.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.6 | 5.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.6 | 9.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.6 | 3.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.6 | 13.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.5 | 19.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.5 | 17.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.5 | 2.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.5 | 17.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.5 | 7.9 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.5 | 29.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.5 | 13.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.5 | 24.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.5 | 38.0 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 0.4 | 13.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.4 | 5.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.4 | 16.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.4 | 14.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.4 | 11.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.4 | 7.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.3 | 5.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.3 | 3.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.3 | 6.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.3 | 9.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.3 | 6.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.3 | 12.8 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.3 | 9.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.3 | 5.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.3 | 2.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.3 | 24.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.3 | 4.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.3 | 3.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.3 | 7.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.3 | 6.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.3 | 3.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.3 | 3.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.2 | 10.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.2 | 13.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.2 | 5.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.2 | 3.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.2 | 5.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.2 | 3.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.2 | 4.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.2 | 14.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.2 | 4.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.2 | 5.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.2 | 11.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.2 | 5.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.2 | 6.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.2 | 2.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.2 | 6.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.2 | 2.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.2 | 3.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 23.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.1 | 4.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 6.9 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.1 | 4.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 4.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 3.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.1 | 3.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 4.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.1 | 1.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 1.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 2.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.1 | 3.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 14.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 2.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.1 | 1.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 3.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 1.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 2.8 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.1 | 2.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 0.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 1.0 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
| 0.1 | 1.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 0.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 13.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 1.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 3.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 1.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 1.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 1.8 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.0 | 0.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.0 | 3.2 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
| 0.0 | 1.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.0 | 2.6 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.0 | 0.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 0.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.0 | 1.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.0 | 1.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.0 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.0 | 1.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.5 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
| 0.0 | 0.3 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.0 | 0.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.0 | 0.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 1.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.3 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 0.0 | 0.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |